← Leaderboards
Ohannes Kevork Melemedjian
University Of Maryland Baltimore
$5,875,364
Attributed
$7,885,727
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.1M · FY2020–24$10M$7.5M$5M$2.5M$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,885,727 · 3
By mechanism
R01$7,885,727 · 3
Top collaborators
- Richard J Traub3 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Richard J Traub$7,380,364
- Jin Y Ro$11,441,623
- Zhongjun Jon Wu$10,834,979
- Susan G Dorsey$16,761,780
- Ke Ren$10,649,004
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectPainInnovationMolecularMetabolismValidationMetabolicNew Therapeutic TargetOpioidInjuryChronicAnimalsEnzymesAcute PainNovel TherapeuticsBiochemicalMitochondriaMediatingChronic PainAdoptedAfferent NeuronsChronic Painful ConditionImaging ModalityKnock-Down
Grant awards (7)
Novel target identification for treatment of chronic overlapping pain using multimodal brain imaging$740,081
R01 · FY2024 · DE
Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy$388,750
R01 · FY2024 · CA · contact PI
Validating ASCT2 for the Treatment of Chronic Postsurgical Pain$386,250
R01 · FY2024 · NS · contact PI
Novel target identification for treatment of chronic overlapping pain using multimodal brain imaging$300,321
R01 · FY2022 · DE
Novel target identification for treatment of chronic overlapping pain using multimodal brain imaging$2,980,325
R01 · FY2020 · DE
Validating ASCT2 for the Treatment of Chronic Postsurgical Pain$1,545,000
R01 · FY2020 · NS · contact PI
Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy$1,545,000
R01 · FY2020 · CA · contact PI